Nabih Alsheikh, MD
Sleep Medicine · Hattiesburg, MSNPI 1023073251
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $424 of the $524 with a category attached, or 80.9%. 7 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 32.3% of the total. Reporting peaked in 2019 at $179 and has fallen 67.5% since, to $58 in 2025.
Across 16 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$169
- Harmony Biosciences LLC$92
- Teva Pharmaceuticals USA, Inc.$86
- Axsome Therapeutics, Inc.$85
- Philips North America LLC$55
- 3b Medical, Inc.$18
- plus $18 from 1 others
What the payments were for
- Food & beverage$42481%
- Education$10019%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 4 | $169 |
| Harmony Biosciences LLC | 5 | $92 |
| Teva Pharmaceuticals USA, Inc. | 1 | $86 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Philips North America LLC | 1 | $55 |
| 3b Medical, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
How this compares
Too few sleep medicine providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 53 | $8,016 |
| Modafinil | 24 | $1,141 |
| Quetiapine Fumarate | 57 | $634 |
| Gabapentin | 92 | $630 |
| Trazodone Hcl | 152 | $474 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $302 |
| Ropinirole Hcl | 23 | $50 |
| Clonazepam | 22 | $41 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Hattiesburg
- Geoffrey HartwigHattiesburg$19
- Brenda HinesFlowood$56K
- Andrea LewisJackson$36K
- Christopher KarcherOcean Springs$26K
- John DouglasGulfport$8K
- Gowdhami MohanClarksdale$5K
- Sanjay RatnakantSouthaven$2K
- John BoswellColumbus$2K
- Kary WhiteheadMeridian$2K
- Mohammad UllahJackson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.